Royalty Report: Drugs, Nutrition, Nutraceutical – Collection: 28159

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 6

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 6

Primary Industries

  • Drugs
  • Nutrition
  • Nutraceutical
  • Supplements
  • Therapeutic
  • Food
  • Veterinary
  • Healthcare

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 28159

License Grant
The Licensee has an agreement for formulas developed by the Licensors.
License Property
The formulas is for specialty health and nutritional products.

The product line is comprised of herbal formulas and nutritional supplement formulas in the following categories

      *     Weight-loss and fat management.

      *     Cardiovascular conditions.

      *     Antioxidant protection.

      *     Memory enhancement and senility prevention.

      *     Prostate protection and BHP reversal.

      *     Impotency reversal and sexual enhancement.

      *     Detoxification procedures.

      *     Daily nutritional requirements.

Field of Use
The Licensee is in the business of the sale of specialty health and nutritional products.

IPSCIO Record ID: 6593

License Grant
The Licensor, a Spanish biotech company, granted an exclusive  License to use, commercialize, market and distribute the Products in all countries located in North America and South America. The Licensee shall have the right during the continuance of this Agreement to enter into Agreements with other persons, firms or corporations, giving and granting to them or any of them the right to enjoy, commercialize and exploit, use and sell the Products in the territory.
License Property
LIST OF PRODUCTS

Product Code
Product Identifying Number
Description of Product

AOF
                 N10500101
                 Antioxidant formula

AH-FLO
                 N10500501  
                 Cardiovascular health extract

JHF
                 N10500201
                 Herbal formula for joint health

HGF
                 N10500301
                 Formula for reduction of a chronic disease risk factor

NB-VAL40
N10500401
                 Sedative formula based in valerian extract

Field of Use
The License anticipates that several of these newly in-licensed compounds will enter clinical testing while others will move directly into non-clinical pre-commercialization pathways as nutritional food supplements.

IPSCIO Record ID: 117913

License Grant
The Company and Licensor entered into agreements for the exclusive licensing of glucarate for colon and liver applications, which required the Company to pay royalty payments on sales of certain licensed products.  The license agreement is for delivery of glucarate in certain health supplements which required the Company to purchase all Calcium D-glucarate from Licensor.  The Company has exclusive rights to use D-glucarate salts (Patented Materials).
License Property
These certain patent rights pertaining to the use of glucarate salts and their derivatives in a sustained release form specifically for the nutritional support of one of the bodys major mechanisms for ridding itself of carcinogens is a process referred to as glucuronidation. The agreement provided for the exclusive licensing of certain formulas, which contain vitamins, minerals, herbal extracts and antioxidants that incorporate the glucarate salt, Calcium D-glucarate for lung, breast and prostate health.  These certain formulas for the delivery of glucarate are used in health supplements are for breast, prostate, lung, colon and liver health.
Field of Use
This agreement pertains to the drug industry relating to health supplements.

IPSCIO Record ID: 224355

License Grant
Licensee is granted a license to market nutritional supplements under the TapouT XT name to retail locations worldwide.
License Property
TapouT XT is a nutritional supplement that uses micro molecular formulae and a utilization of an oral spray to provide faster and more efficient absorption.
Field of Use
This agreement pertains to nutritional supplements.

IPSCIO Record ID: 203496

License Grant
Licensor grants to The United Kingdom Licensee an exclusive, worldwide license to use the Licensor Technology for all activities relating to
– the manufacture of Phytase by a third party solely for sale to Licensee
– the use and sale of Phytase for the manufacture of Products for the Animal Health Field and Animal Nutrition Field; .and
– the manufacture, use and sale of Products for the Animal Health Field and Animal Nutrition Field.
License Property
The Products shall mean products containing Phytase.  Phytase shall mean an enzyme from E. Coli B strain ATCC #11303 that hydrolyzes phytic acid and which is manufactured under the licenses granted by this License Agreement.

When novel phytase enzyme is used as an additive in animal feed applications allows higher utilization of phytic acid phosphates from the feed, thereby increasing its nutritional value. The addition of phytase to animal feed reduces the need for inorganic phosphorus supplementation and lowers the level of harmful phosphates that are introduced to the environment through animal waste, resulting in inorganic phosphate cost savings and a significant reduction in environmental pollution.

Field of Use
The field of use is for animal health and nutrition.  The Animal Health field shall mean a field of activities relating to products which directly or indirectly enhance an animals nutrition, growth, health or well-being and which customarily require a veterinarians prescription in the United States.   The Animal Nutrition field shall mean a field of activities relating to products which directly or indirectly enhance an animals nutrition, growth, health or well-being and which customarily do not require a veterinarians prescription in the United States.

IPSCIO Record ID: 204801

License Grant
Both parties entered into an agreement to license four proprietary formulas.
License Property
Proprietary Formulas

ProFormaxCR, an all-natural fitness supplement that is intended to promote adult stem cell recruitment, HPA and endocrine stabilization, inflammatory regulators, decrease body fat, hormonal support and lean muscle tissue enhancement.

SomniaPM, a natural product designed for sleep that contains 15 active ingredients, including melatonin, valerian, and hydroxytryptophan, as well as natural botanicals used for many years for sleep and relaxation.

AlertNRG, an all-natural mental energy booster containing caffeine, guarana, 3 natural botanicals used for many years to produce energy, B vitamins, indium sulfate and eggplant extract.

Man Up®, combines saw palmetto extract containing beta sistosterol, with yohimbe, an age-old aphrodisiac and icariin derivatives from the horney goat weed (epimedium icariia) extract to produce an all-natural male erectile and prostate health product recommended as a daily dietary supplement for vigorous and active men who seek a healthy sex life and maintain robust prostate health.

Field of Use
This agreement pertains to the consumer goods / healthcare industry.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.